Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 639-693-5 | CAS number: 180637-88-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- December 1997
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted 17 July 1992
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- in vivo study was conducted prior to the availability of the LLNA or other in-vitro tet methods
Test material
- Reference substance name:
- (R)-1-Acetyl-3-(1-methyl-2-pyrrolidinyl methyl)-5-[2-(phenylsulphonyl)vinyl] -1H-indole
- EC Number:
- 639-693-5
- Cas Number:
- 180637-88-1
- Molecular formula:
- C24 H26 N2 O3 S
- IUPAC Name:
- (R)-1-Acetyl-3-(1-methyl-2-pyrrolidinyl methyl)-5-[2-(phenylsulphonyl)vinyl] -1H-indole
- Test material form:
- solid: bulk
- Details on test material:
- brown crystalline solid
Constituent 1
- Specific details on test material used for the study:
- Brown Solid
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- At the start of the main study the animals weighed 301 to 353g, and were approximately eight to twelve weeks old. After an acclimatisation period of at least five
days, each animal was selected at random and given a number unique within the study which was written on a small area of clipped rump using a black indelible marker-pen.
The animals were housed singly or in pairs in solid-floor polypropylene cages furnished with woodflakes. Free access to mains tap water and food was allowed throughout the study. For the main study the animal room was maintained at a temperature of 19 to 22°C and relative humidity of 46 to 67%. The rate of air exchange was
approximately fifteen changes per hour and the lighting was controlled by a time switch to give twelve hours continuous light and twelve hours darkness.
Study design: in vivo (non-LLNA)
- No. of animals per dose:
- 4
- Details on study design:
- Initial Test: Four concentrations of test material were investigated (1%, 5%, 10% and 25% w/v in arachis oil BP). A total of four guinea pigs were used, each guinea pig receiving four 0.1 ml injections of only one concentration of test material. The degree of erythema at the injection sites was assessed approximately 24, 48 and 72 hours and 7 days after injection according to the Draize scale shown in Appendix X. The degree of oedema was not evaluated. Any evidence of systemic toxicity was also recorded. The highest concentration that caused only mild to moderate skin irritation, and which was well tolerated systemically, was selected for the intradermal induction stage of the main study.
- Positive control substance(s):
- not specified
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25% w/w in arachis oil BP
- No. with + reactions:
- 10
- Total no. in group:
- 20
- Clinical observations:
- very slight to well-defined erythema with very slight to slight oedema
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Positive skin responses (very slight to well-defined erythema with very slight to slight oedema) were noted at the challenge sites of all test group animals at the 24-hour observations. Other adverse skin reactions noted included brown staining caused by the test material, small superficial scattered scabs, desquamation, superficial cracking of the epidermis and crust formation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25% w/w in arachis oil BP
- No. with + reactions:
- 10
- Total no. in group:
- 20
- Clinical observations:
- very slight to well-defined erythema with very slight to slight oedema
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Other adverse skin reactions noted included brown staining caused by the test material, small superficial scattered scabs, desquamation, superficial cracking of the epidermis and crust formation. These adverse skin reactions precluded an accurate assessment of the degree of oedema and for erythema at the challenge sites of three test group animals at the 48-hour observation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 25% w/w in Arachis Oil BP
- No. with + reactions:
- 9
- Total no. in group:
- 20
- Clinical observations:
- very slight to well-defined erythema with very slight to slight oedema
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Other adverse skin reactions noted included brown staining caused by the test material, small superficial scattered scabs, desquamation, superficial cracking of the epidermis and crust formation. These adverse skin reactions precluded an accurate assessment of the degree of oedema and for erythema at the challenge sites of five of the test group animals at the 72-hour observation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 50% Arachis Oil BP
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No erythema or oedema was noted at the challenge sites of control group animals at 24, 48 or 72 hours
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- incidents of brown staining were observed
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50% w/w in Arachis Oil B
- No. with + reactions:
- 19
- Total no. in group:
- 20
- Clinical observations:
- very slight to well-defined erythema (grades 1 to 2) and incidents of very slight oedema
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50% in Arachis Oil BP
- No. with + reactions:
- 19
- Total no. in group:
- 20
- Clinical observations:
- Positive skin responses ,very slight to well-defined erythema (grades 1 to 2) and incidents of very slight oedema
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Other adverse reactions noted were desquamation, brown staining caused by the test material, small superficial scattered scabs, crust formation, superficial cracking of the epidermis and hardened, light-brown scab. These adverse reactions precluded accurate assessment of erythema and oedema at five challenge sites at the 48-hour observation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 50% in Arachis Oil BP
- No. with + reactions:
- 19
- Total no. in group:
- 20
- Clinical observations:
- Positive skin responses (very slight to well-defined erythema grades 1 to 2) and incidents of very slight oedema. An additional observation was made at 72 hours as some of these reactions had increased in severit
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Other adverse reactions noted were desquamation, brown staining caused by the test material, small superficial scattered scabs, crust formation, superficial cracking of the epidermis and hardened, light-brown scab. These adverse reactions precluded accurate assessment of erythema and oedema four challenge sites at the 72-hour observation.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
